
Sign up to save your podcasts
Or
Shadd Dales digs into a big win in the cannabis industry, with special guest Aras Azadian from Avicanna Inc. (TSX: AVCN). The company just had its best year yet, hitting $25.5 million in revenue—a massive 52% jump from the year before. Aras shares what fueled this success and what’s next for Avicanna in 2025.We breakdown key metrics that included improved gross margins, up to 51%, and the 94% surge in gross profits. The discussion also touches on the company’s efforts in reducing its adjusted EBITDA loss by 68%, signaling a strong move toward profitability.Plus, we discuss the podcast explores Avicanna’s global expansion strategy, its key priorities for 2025 and 2026, and the recent news about delays in financial filings. This is an episode that includes latest cannabis trends, the international medical marijuana opportunity, and and market insights.0:00:00 - Intro0:01:07 - Discussion of Avicanna's best year and medical business model0:04:04 - International medical cannabis opportunities0:08:06 - Revenue growth and Shoppers Drug Mart acquisition0:11:24 - Gross margin improvements and business strategy0:15:24 - Engagement with Canadian Pain Society0:19:56 - Research and development studies0:23:52 - Future growth potential in European and other markets0:25:48 - Explanation of audit filing delay#CannabisNews #CannabisEconomy #CannabisCommunity #MedicalMarijuana #MarijuanaStocks #CannabisInvestment #CannabisTrends #CBD #CannabisRescheduling #marijuanarescheduling Want to see the last week's recap? • SNDL Headlines a Volatile Week in Can... Want to see more Cannabis Reform videos? • Can Cannabis Stocks Stay Resilient Am... • Hemp Market Chaos: Is It Time for a C... • Trump’s Drug Policy Skips Cannabis, R... • Can Senator Tim Scott REALLY Pass SAF... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
5
77 ratings
Shadd Dales digs into a big win in the cannabis industry, with special guest Aras Azadian from Avicanna Inc. (TSX: AVCN). The company just had its best year yet, hitting $25.5 million in revenue—a massive 52% jump from the year before. Aras shares what fueled this success and what’s next for Avicanna in 2025.We breakdown key metrics that included improved gross margins, up to 51%, and the 94% surge in gross profits. The discussion also touches on the company’s efforts in reducing its adjusted EBITDA loss by 68%, signaling a strong move toward profitability.Plus, we discuss the podcast explores Avicanna’s global expansion strategy, its key priorities for 2025 and 2026, and the recent news about delays in financial filings. This is an episode that includes latest cannabis trends, the international medical marijuana opportunity, and and market insights.0:00:00 - Intro0:01:07 - Discussion of Avicanna's best year and medical business model0:04:04 - International medical cannabis opportunities0:08:06 - Revenue growth and Shoppers Drug Mart acquisition0:11:24 - Gross margin improvements and business strategy0:15:24 - Engagement with Canadian Pain Society0:19:56 - Research and development studies0:23:52 - Future growth potential in European and other markets0:25:48 - Explanation of audit filing delay#CannabisNews #CannabisEconomy #CannabisCommunity #MedicalMarijuana #MarijuanaStocks #CannabisInvestment #CannabisTrends #CBD #CannabisRescheduling #marijuanarescheduling Want to see the last week's recap? • SNDL Headlines a Volatile Week in Can... Want to see more Cannabis Reform videos? • Can Cannabis Stocks Stay Resilient Am... • Hemp Market Chaos: Is It Time for a C... • Trump’s Drug Policy Skips Cannabis, R... • Can Senator Tim Scott REALLY Pass SAF... Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook: / thedalesreport Twitter: / thedalesreport Instagram: / dalesreport LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have. https://thedalesreport.com/website-te...
39 Listeners
3,705 Listeners
95 Listeners
1,837 Listeners
205 Listeners
68 Listeners
5,282 Listeners
390 Listeners
104 Listeners
28,288 Listeners
8,558 Listeners
118 Listeners
6 Listeners
12 Listeners
1,024 Listeners